Select a Region North America

How Manufacturers Can Optimize and Organize Support Services for Specialty Drugs Through a Patient Touchpoint Analysis

Currently representing almost half of the overall pharmacy benefit spend, specialty drugs are classified as being high-complexity, high-touch and high-cost medications. As healthcare providers (HCPs) and patients turn to these more expensive products to treat rare, complex and/or chronic medical conditions, the need for increased patient education, adherence and support services has been elevated. To best understand the patient experience and their needs, healthcare systems are turning to patient journey mapping. Using this tool, healthcare entities such as the provider’s practice, the insurer, the specialty pharmacy and manufacturers are developing and providing their versions of patient support services.

Click here to download the white paper.

Author Team
no-image

EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…